Life Sciences

Hopkinton-based Spring Bank Pharmaceuticals wants to raise $37.5 million to fund clinical trials, studies and research and other corporate purposes.

Boston Scientific will soon submit the final technical module to the U.S. Food and Drug Administration for a heart valve product.

Boston Scientific is showing no signs of slowing its aggressive acquisition strategy as the medical device giant is set to acquire a privately held obstructive disease firm for up to $160 million.

Marlborough medical imaging giant Hologic will acquire breast health imaging company Faxitron Bioptics for $85 million.

Boston Scientific has no immediate plans to launch a high-frequency spinal cord stimulation product in the wake of recent rulings in a patent infringement case.

Holliston medical device maker Harvard Bioscience is hoping to get out of the red as its second quarter revenues of $31.5 million reached an all-time high.

Marlborough medical imaging device firm Hologic launched an initiative Wednesday to expand affordable access to molecular testing for HIV, heptatits B and C, and HPV.

Canadian private investment firm TRC Capital wants to invest up to $95.7 million in Boston Scientific in a mini-tender offer, but the company says the firm's per-share offering is well below market value.

Marlborough medical device giant Boston Scientific reported a $555 million profit and nearly $2.5 billion in sales for the second quarter, near the top end of the company's guidance range.

A Natick weight loss device company has begun a clinical trial in the U.S. with the hopes of soon gaining U.S. Food and Drug Administration approval.